Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
latest_posts
- 1
Orbán orders stop to gas deliveries to Ukraine via Hungary from July - 2At least 490 protesters killed in Iran, activists say
- 3Bondi Beach survivor criticizes police for inaction during terror attack
- 4Nature carves colossal snowman in Siberia | Space photo of the day for Jan. 2, 2026
- 5Mom finds out she has cancer after noticing something was off while breastfeeding
- Iconic iceberg turns blue, on verge of totally disintegrating, NASA says
- Impact of NIH funding reductions felt in cancer and infectious disease trials
- Qatar, Ireland accuse Israel of using chemical weapons on Palestinians, demand watchdog probe use
- Figure out How to Pick the Right Toothbrush for You
- West Antarctica’s history of rapid melting foretells sudden shifts in continent’s ‘catastrophic’ geology
- Ultra-Orthodox protests erupt across Israel on haredi IDF enlistment day
- Weight-loss pill approval set to accelerate food industry product overhauls
- The Main 20 Gaming Control center Ever
- How stripping diversity, equity and inclusion from health care may make Americans sicker
